Sonim Technologies INC 10-Q quarterly reports

DNA X, Inc. filed its Q2 2026 Form 10-Q, detailing a strategic shift from hardware manufacturing to a cryptocurrency trading platform, alongside significant net losses and a material weakness in internal controls.

DNA X, Inc. reports Q1 2026 results following the divestiture of its legacy hardware business and transition to an AI-driven cryptocurrency trading platform.

Sonim Technologies reports increased quarterly net loss and significant cash burn, raising substantial doubt about its ability to continue as a going concern, while pursuing an asset sale and strategic alternatives.

Sonim Technologies reported an increased net loss for Q2 2025 and is pursuing a strategic asset sale and reverse merger to maximize stockholder value.

Sonim Technologies' Q1 2025 results show a slight revenue decrease but improved gross profit due to customer allowance expirations, alongside strategic expansion and new product launches.

Sonim Technologies experienced a significant revenue decrease in Q3 2024 due to a strategic shift away from white-label products, while launching new rugged devices and hotspots.

Sonim Technologies experienced a significant revenue decrease in Q2 2024 due to a strategic shift away from white-label products, while preparing for new product launches in the second half of the year.

Sonim Technologies experienced a revenue decrease in Q1 2024 due to a transition away from white-label products, while preparing for new product launches in the second half of the year.